MedPath

asunadi Vati and Pippaladyasava in the management of Loss of appetite.

Phase 2
Conditions
Health Condition 1: K929- Disease of digestive system, unspecified
Registration Number
CTRI/2023/01/049085
Lead Sponsor
Central Council for Research in Ayurvedic Sciences. New-Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex with age between 18 and 60 years.

2.Patients having any six sign and symptoms of Agnimandya out of 10 along with reduced Abhyavaharan Shakti, (capacity to eat), Jarana Shakti (capacity to digest), and Ruchi (appetite) for the past one week. Avipaka, Aruchi, Udaragaurava, Shirogaurava, Praseka, Chhardi, Kasa, Shwasa, Gatrasada, Malavarodha.

3.Willing to participate in the study.

Exclusion Criteria

1.Patients of age <18 years and >60 years.

2.Patients in whom Agnimandya is caused due to intake of medicine.

3.Patients having Tikshagni (hyper functioning of digestion and metabolic activities) and Samagni (moderate Agni)

4.Patients having any established disease of Gastro-intestinal tracts.

5.Immuno compromised states and patients with systemic infections or known cases of AIDS, HIV, STD etc.

6.Patients with severe/history of cardiac, hepatic, cerebrovascular disease, pulmonary dysfunction, malignancy, chronic uncontrolled systemic diseases or renal disorder (S. Creatinine >1.2 mg/dl) etc or poorly controlled Hypertension (Blood pressure more than 160/100mm of Hg), uncontrolled Diabetes Mellitus (HbA1c >= 8), or any other serious medical illness.

7.Patients on medication with corticosteroids or any other drugs that may have an influence on the outcome of the study.

8.History of hypersensitivity to the trial drug or any of its ingredients.

9.Patients who have completed participation in any other clinical trial during the past three months.

10. Any other condition, which the Investigator thinks, may jeopardize the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in sign and symptoms of Agnimandya.Timepoint: Day 0, Day 7, Day 14 and Day 21
Secondary Outcome Measures
NameTimeMethod
Change in Agnibala (Agni Pariksha tool developed by CCRAS).Timepoint: Day 0, Day 14 and Day 21;Change in quality of life by using SF-36 ScoreTimepoint: Day 0, Day 14 and Day 21
© Copyright 2025. All Rights Reserved by MedPath